Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia (Q167209): Difference between revisions
From geokb
(Changed label, description and/or aliases in en, and other parts: modified description with assistance from Llama 3.1) |
(Changed an Item: moved OpenAlex ID to its dedicated external ID datatype for consistency) |
||
| Property / same as | |||
| Property / same as: https://openalex.org/T11157 / rank | |||
| Property / OpenAlex ID | |||
| Property / OpenAlex ID: T11157 / rank | |||
Normal rank | |||
Revision as of 12:16, 8 September 2024
Study of CLL's genetic mutations and treatment options.
- Chronic Lymphocytic Leukemia
- Genomic Aberrations
- BTK Inhibitors
- Rituximab
- Ibrutinib
- Prognostic Factors
- TP53 Mutation
- Waldenström Macroglobulinemia
- Immunoglobulin Mutation
- Therapeutic Targets
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia |
Study of CLL's genetic mutations and treatment options. |
|
